• 1
    Ashwell G, Morrell AD. The role of surface carbohydrates in the hepatic recognition and transport of circulation glycoproteins. Adv Enzymol 1974; 4: 99128.
  • 2
    Fiume L, Mattioli A, Balboni PG, Tognon M, Barbanti-Brodano- G, de Vries J, Wieland. Enhanced inhibition of virus DNA synthesis in hepato-cytes by trifluorothymidine coupled to asialofetuin. FEBS Lett 1979; 103: 4751.
  • 3
    Fiume L, Mattioli A, Busi C, Balboni PG, Barbanti-Brodano G, De Vries J, Altmann R, Wieland T. Selective inhibition of Ectromelia virus DNA synthesis in hepatocytes by adenine-9-β-D-arabinofura-noside (ara-A) and adenine-9-β-D-arabinofuranoside 5′-monophos-phate (ara-AMP) conjugated to asialofetuin. FEBS Lett 1980; 116: 186188.
  • 4
    Fiume L, Busi C, Mattioli A. Lactosminated human serum albumin as hepatotropic drug carrier: rate of uptake by mouse liver. FEBS Lett 1982; 146: 4246
  • 5
    Fiume L, Busi C, Mattioli A, Balboni PG, Barbanti-Brodano G. Hepato-cyte targeting of adenine-9-β-D-arabinofuranoside 5′-monophosphate (ara-AMP) coupled to lactosaminated albumin. FEBS Lett 1981; 129: 261264.
  • 6
    Fiume L, Busi C, Preti P, Spinosa G. Conjugates of ara-AMP with lactosaminated albumin: a study on their immunogenicity in mouse and rat. Cancer Drug Deliv 1987; 4: 145150.
  • 7
    Cerenzia MR Torranin, Fiume L, Busi C, Mattioli A, Di Stefano G, Gervasi GB, Brunetto MR, Piantino P, Verme G, Bonino F. Inhibition of hepatitis B virus replication by adenine arabinoside monophosphate coupled to lactosaminated albumin: efficacy and minimal active dose. J Hepatol 1994; 2: 307309.
  • 8
    Franssen EJF, Jansen RW, Vaalburg M, Meijer DKF. Hepatic and intra-hepatic targeting of an anti-inflammatory agent with human serum albumin and neoglycoproteins as carrier molecules. Biochem Pharmacol 1993; 45: 12151226.
  • 9
    Nagelkerke JF, Barto KP, Van Berkel THJC. In vivo and in vitro uptake and degradation of acetylated LDL by rat liver endothelial, Kupffer and parenchymal cells. J Biol Chem 1983; 258: 1222112227.
  • 10
    Van Berkel THJC, De Rijke YB, Kruijt JK. Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. J Biol Chem 1991; 266: 22822289.
  • 11
    Fox ES, Thomas P, Broitman SA. Clearance of gut derived endotoxins by the liver: Release and modification of 3H, 14C-lipopolysaccaride by isolated rat Kupffer cells. Gastroenterology 1989; 13: 5059.
  • 12
    Winwood PJ, Arthur MJP. Kupffer cells: their activation and role in animal models of liver injury an human liver disease. Semin Liver Dis 1993; 8: 15501554.
  • 13
    Peters T, Karck U, Decker K. Interdependence of tumor necrosis factor prostaglandin E and protein synthesis in lipopolysaccharide-exposed rat Kupffer cells. Eur J Biochem 1990; 191: 583589.
  • 14
    Hewett JA, Joan PA, Kunkel SL, Roth RA. Relationship between tumor necrosis factor α and neutrophils in endotoxin-induced liver injury. Am J Physiol 1993; 265: Gl011G1015.
  • 15
    Karck U, Peters T, Decker K. The release of tumor necrosis factor from endotoxin-stimulated rat Kupffer cells is regulated by prostaglandin E2 and dexamethasone. J Hepatol 1988; 7: 352361.
  • 16
    Kuiper J, Zijlstra FJ, Kamps JAAM, Van Berkel THJC. Identification of prostaglandin D,'as the major eicosanoid from liver endothelial and Kupffer cells. Biochim Biophys Acta 1988; 959: 143152.